A group sequential design can stop early for efficacy or futility, reducing expected sample size, cost, and time and limiting exposure to an inferior treatment. Its disadvantages include greater design and operational complexity, a potentially larger maximum sample size, and the need for adjusted stopping boundaries and inference to preserve the type I error after repeated looks.
Let be the bivariate normal density with the mean and covariance from part ii. Continuing and then not rejecting means and , so its probability is
The trial uses observations per arm if it stops at the first analysis and if it continues. Since ,Therefore the expected per-arm sample size is
Articles by others on the same topic
There are currently no matching articles.